Shield Therapeutics plc (STX.L) announced that Greg Madison, Chief Executive Officer, will be stepping down from the Board by mutual consent to pursue other opportunities and will be leaving the Company with immediate effect.
Anders Lundstrom, an independent non-executive Director of the company, has been appointed as interim Chief Executive Officer. Based in Boston, Massachusetts, Anders brings extensive international and US senior commercial and general management experience. He has held leadership roles at various pharmaceutical and biotech firms, including AstraZeneca, Biogen, and Orexo, where he served as president and CEO.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.